- Home
- TRNS vs HQL Comparison
TRNS vs HQL Comparison
Compare TRNS & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TRNS | HQL |
|---|---|---|
| Founded | 1964 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Investment Managers |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 542.9M | 529.4M |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | TRNS | HQL |
|---|---|---|
| Price | $89.14 | $16.82 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $116.00 | N/A |
| AVG Volume (30 Days) | ★ 162.7K | 103.9K |
| Earning Date | 05-18-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.56% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.57 | ★ 0.79 |
| Revenue | ★ $331,877,000.00 | N/A |
| Revenue This Year | $21.75 | N/A |
| Revenue Next Year | $7.55 | N/A |
| P/E Ratio | $153.89 | ★ $21.42 |
| Revenue Growth | ★ 19.20 | N/A |
| 52 Week Low | $50.23 | $12.50 |
| 52 Week High | $94.76 | $18.46 |
Technical Indicators
Market Signals| Indicator | TRNS | HQL |
|---|---|---|
| Relative Strength Index (RSI) | 62.98 | 39.06 |
| Support Level | $69.56 | $16.40 |
| Resistance Level | $91.45 | $17.40 |
| Average True Range (ATR) | 6.55 | 0.32 |
| MACD | 1.51 | -0.10 |
| Stochastic Oscillator | 83.26 | 18.18 |
Price Performance
Historical ComparisonAbout TRNS Transcat Inc.
Transcat Inc is involved in providing calibration and laboratory instrument services and the distribution of test, measurement, and control instrumentation. The product and services portfolio of the company consists of calibration instruments, dimensional measuring tools, Electrical test instruments, pressure measurement, and others. The firm has Service and Distribution operating segments. The company derives the majority of its revenues from the Service segment. The firm promotes and sells its products under brand names such as Extech, FLIR, Fluke, Keysight, Megger, and others.
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.